National gains Guidant device tracking contract:
This article was originally published in Clinica
Executive Summary
National Computer Systems has been selected by Guidant to track devices manufactured by Guidant's:w cardiac rhythm management group. National's computer-managed system is designed to allow companies to implement the FDA's tracking requirements across 30 different device categories, so that manufacturers can quickly trace their devices to an individual physician and his or her patient group. There are currently thought to be eight million such devices being operated in the US with around a million manufactured each year.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.